BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30516811)

  • 1. Use of Big Data to Estimate Prevalence of Defective DNA Repair Variants in the US Population.
    Pugh J; Khan SG; Tamura D; Goldstein AM; Landi MT; DiGiovanna JJ; Kraemer KH
    JAMA Dermatol; 2019 Jan; 155(1):72-78. PubMed ID: 30516811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype-phenotype correlation of xeroderma pigmentosum in a Chinese Han population.
    Sun Z; Zhang J; Guo Y; Ni C; Liang J; Cheng R; Li M; Yao Z
    Br J Dermatol; 2015 Apr; 172(4):1096-102. PubMed ID: 25256075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa.
    Soufir N; Ged C; Bourillon A; Austerlitz F; Chemin C; Stary A; Armier J; Pham D; Khadir K; Roume J; Hadj-Rabia S; Bouadjar B; Taieb A; de Verneuil H; Benchiki H; Grandchamp B; Sarasin A
    J Invest Dermatol; 2010 Jun; 130(6):1537-42. PubMed ID: 20054342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xeroderma pigmentosum: low prevalence of germline XPA mutations in a Brazilian XP population.
    Santiago KM; França de Nóbrega A; Rocha RM; Rogatto SR; Achatz MI
    Int J Mol Sci; 2015 Apr; 16(4):8988-96. PubMed ID: 25913378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep intronic founder mutations identified in the
    Senju C; Nakazawa Y; Oso T; Shimada M; Kato K; Matsuse M; Tsujimoto M; Masaki T; Miyazaki Y; Fukushima S; Tateishi S; Utani A; Murota H; Tanaka K; Mitsutake N; Moriwaki S; Nishigori C; Ogi T
    Proc Natl Acad Sci U S A; 2023 Jul; 120(27):e2217423120. PubMed ID: 37364129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
    Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of Xeroderma Pigmentosum Groups A and C by Detection of Two Prevalent Mutations in West Algerian Population: A Rapid Genotyping Tool for the Frequent XPC Mutation c.1643_1644delTG.
    Bensenouci S; Louhibi L; De Verneuil H; Mahmoudi K; Saidi-Mehtar N
    Biomed Res Int; 2016; 2016():2180946. PubMed ID: 27413738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
    Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
    Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients.
    Khan SG; Oh KS; Shahlavi T; Ueda T; Busch DB; Inui H; Emmert S; Imoto K; Muniz-Medina V; Baker CC; DiGiovanna JJ; Schmidt D; Khadavi A; Metin A; Gozukara E; Slor H; Sarasin A; Kraemer KH
    Carcinogenesis; 2006 Jan; 27(1):84-94. PubMed ID: 16081512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel XPC pathogenic variant detected in archival material from a patient diagnosed with Xeroderma Pigmentosum: a case report and review of the genetic variants reported in XPC.
    Rivera-Begeman A; McDaniel LD; Schultz RA; Friedberg EC
    DNA Repair (Amst); 2007 Jan; 6(1):100-14. PubMed ID: 17079196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetic analysis of 16 XP-C patients from Germany: environmental factors predominately contribute to phenotype variations.
    Schäfer A; Hofmann L; Gratchev A; Laspe P; Schubert S; Schürer A; Ohlenbusch A; Tzvetkov M; Hallermann C; Reichrath J; Schön MP; Emmert S
    Exp Dermatol; 2013 Jan; 22(1):24-9. PubMed ID: 23173980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion of the genotypic and phenotypic spectrum of xeroderma pigmentosum in Chinese population.
    Zhang J; Cheng R; Yu X; Sun Z; Li M; Yao Z
    Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):58-63. PubMed ID: 27982466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carrier frequency of the recurrent mutation c.1643_1644delTG in the XPC gene and birth prevalence of the xeroderma pigmentosum in Morocco.
    Doubaj Y; Laarabi FZ; Elalaoui SC; Barkat A; Sefiani A
    J Dermatol; 2012 Apr; 39(4):382-4. PubMed ID: 22211393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the XPD gene in xeroderma pigmentosum group D cell strains: confirmation of genotype-phenotype correlation.
    Kobayashi T; Uchiyama M; Fukuro S; Tanaka K
    Am J Med Genet; 2002 Jul; 110(3):248-52. PubMed ID: 12116233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels.
    Chavanne F; Broughton BC; Pietra D; Nardo T; Browitt A; Lehmann AR; Stefanini M
    Cancer Res; 2000 Apr; 60(7):1974-82. PubMed ID: 10766188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. True XP group E patients have a defective UV-damaged DNA binding protein complex and mutations in DDB2 which reveal the functional domains of its p48 product.
    Rapić-Otrin V; Navazza V; Nardo T; Botta E; McLenigan M; Bisi DC; Levine AS; Stefanini M
    Hum Mol Genet; 2003 Jul; 12(13):1507-22. PubMed ID: 12812979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of internal tumors in DNA repair-deficient xeroderma pigmentosum patients: analysis of four international cohorts.
    Nikolaev S; Yurchenko AA; Sarasin A
    Orphanet J Rare Dis; 2022 Mar; 17(1):104. PubMed ID: 35246173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole Exome Sequencing of a Patient with a Milder Phenotype of Xeroderma Pigmentosum Group C.
    Seo JI; Nishigori C; Ahn JJ; Ryu JY; Lee J; Lee MH; Kim SK; Jeong KH
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cockayne syndrome and xeroderma pigmentosum.
    Rapin I; Lindenbaum Y; Dickson DW; Kraemer KH; Robbins JH
    Neurology; 2000 Nov; 55(10):1442-9. PubMed ID: 11185579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mutation in the XPA gene results in two truncated protein variants and leads to a severe XP/neurological symptoms phenotype.
    Lehmann J; Schubert S; Schäfer A; Laspe P; Haenssle HA; Ohlenbusch A; Gratchev A; Emmert S
    J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2479-82. PubMed ID: 25393472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.